Friedrich Wrba Selected Research

Friedrich Wrba Research Topics

Disease

19	Neoplasms (Cancer) 01/2018 - 01/2003
10	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2002
5	Liver Cirrhosis (Hepatic Cirrhosis) 02/2016 - 08/2002
5	Colonic Neoplasms (Colon Cancer) 11/2012 - 01/2003
5	Carcinoma (Carcinomatosis) 04/2012 - 01/2003
3	Non-alcoholic Fatty Liver Disease 01/2017 - 06/2014
3	Fibrosis (Cirrhosis) 10/2016 - 06/2014
3	Hepatocellular Carcinoma (Hepatoma) 01/2011 - 01/2007
3	Chronic Hepatitis C 01/2008 - 11/2002
2	Colorectal Neoplasms (Colorectal Cancer) 11/2015 - 01/2006
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2015 - 08/2005
2	Liver Diseases (Liver Disease) 02/2015 - 08/2002
2	Infections 04/2011 - 01/2008
1	Esophageal Neoplasms (Esophageal Cancer) 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Liver Cell Adenoma (Hepatocellular Adenoma) 10/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2015
1	Hepatolenticular Degeneration (Wilson's Disease) 07/2015
1	Cholestasis 02/2015
1	Siderosis 02/2015
1	Fatty Liver 06/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2012
1	Stomach Neoplasms (Stomach Cancer) 08/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2011
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2011
1	Oropharyngeal Neoplasms 04/2011
1	Cholangiocarcinoma 01/2011
1	Fatigue 01/2011
1	Diarrhea 01/2011
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2009
1	Ulcerative Colitis 04/2008
1	Hemorrhage 04/2008
1	Necrosis 01/2007
1	Neoplasm Micrometastasis 01/2006
1	Jaundice (Icterus) 09/2005
1	Microsatellite Instability 04/2005

Drug/Important Bio-Agent (IBA)

5	Bevacizumab (Avastin)FDA Link 01/2022 - 06/2015
4	Proteins (Proteins, Gene)FDA Link 11/2015 - 01/2003
4	IronIBA 01/2014 - 08/2002
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2015
3	Messenger RNA (mRNA)IBA 11/2016 - 07/2004
3	gadolinium ethoxybenzyl DTPA FDA Link 02/2016 - 06/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2006 - 01/2003
2	CopperIBA 01/2017 - 07/2015
2	CalciumIBA 10/2016 - 01/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2013 - 10/2008
2	Biological ProductsIBA 11/2012 - 04/2012
2	Cetuximab (Erbitux)FDA Link 04/2012 - 04/2011
2	Thioguanine (Tioguanine)FDA Link 04/2008 - 08/2005
2	InterferonsIBA 01/2008 - 11/2002
2	N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)FDA Link 03/2005 - 12/2002
2	Ribavirin (Virazole)FDA LinkGeneric 06/2004 - 11/2002
1	Procollagen Type IIBA 10/2016
1	Vitamin D FDA LinkGeneric 10/2016
1	AlbuminsIBA 10/2016
1	OsteocalcinIBA 10/2016
1	Parathyroid Hormone (Parathormone)IBA 10/2016
1	Interleukin-10 (Interleukin 10)IBA 11/2015
1	Multidrug Resistance-Associated Protein 2IBA 10/2015
1	Peptides (Polypeptides)IBA 10/2015
1	AnionsIBA 10/2015
1	Phospholipases (Phospholipase)IBA 07/2015
1	AngiopoietinsIBA 06/2015
1	Transaminases (Aminotransferases)IBA 02/2015
1	4-(3-chlorophenylsulfanyl)piperidineIBA 02/2015
1	Syntex adjuvant formulationIBA 06/2014
1	P 11 (P-11)IBA 01/2014
1	Glycoproteins (Glycoprotein)IBA 11/2013
1	Carcinoembryonic AntigenIBA 11/2013
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2012
1	Transcription Factors (Transcription Factor)IBA 05/2012
1	AntigensIBA 04/2012
1	AntibodiesIBA 04/2012
1	Trastuzumab (Herceptin)FDA Link 04/2012
1	dactolisibIBA 08/2011
1	alovudineIBA 08/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2011
1	Cisplatin (Platino)FDA LinkGeneric 04/2011
1	Sorafenib (BAY 43-9006)FDA Link 01/2011
1	thiamine triphosphorate (TTP)IBA 01/2011
1	Tumor Biomarkers (Tumor Markers)IBA 01/2011
1	Thalidomide (Thalomid)FDA Link 10/2008
1	EndostatinsIBA 10/2008
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2008
1	Small Interfering RNA (siRNA)IBA 01/2008
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2008
1	Ethanol (Ethyl Alcohol)IBA 01/2007
1	methyl N-acetylsibirosaminide (MASA)IBA 01/2006
1	Indicators and Reagents (Reagents)IBA 01/2006
1	Pharmaceutical PreparationsIBA 08/2005

Therapy/Procedure

7	Therapeutics 01/2022 - 11/2002
5	Drug Therapy (Chemotherapy) 01/2020 - 01/2011
4	Neoadjuvant Therapy 01/2022 - 08/2011
3	Liver Transplantation 01/2007 - 09/2005
2	Radiotherapy 04/2011 - 04/2002
1	Lasers (Laser) 02/2015
1	Conservative Treatment 04/2011
1	Chemoradiotherapy 04/2011
1	Aftercare (After-Treatment) 01/2009
1	Transplantation 01/2007